Source: Annual Congress 2006 - Pulmonary hypertension: thromo-embolic processes
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Gomez, F. Uresandi, G. Iruin, L. Garcia-Echeberria, P. Sobradillo, P. Losada, A. Gomez, M. Iriberri (Barakaldo, Spain). Recommended uses for indefinite secondary prophylaxis in patients with pulmonary embolism. Eur Respir J 2006; 28: Suppl. 50, 2370

Member's Comments

No comment yet.

Related content which might interest you: Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 Management appropriateness and outcomes of patients with acute pulmonary embolism Source: Eur Respir J, 51 (5) 1800445; 10.1183/13993003.00445-2018 Year: 2018 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021 Year: 2021 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Adequate use of pulmonary embolism clinical prediction rule in COPD patients Source: Eur Respir J 2011; 37: 219-220 Year: 2011 Early discharge of patients with pulmonary embolism: feasibility of domicillary anticoagulation Source: Eur Respir J 2003; 22: Suppl. 45, 219s Year: 2003 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Duration of anticoagulation after isolated pulmonary embolism Source: Eur Respir J 2016; 47:1429-1435 Year: 2016 Algorithms for diagnosing acute pulmonary embolism (whom not to treat?) Source: Annual Congress 2007 - Update on venous thromboembolism Year: 2007 Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Safety of withholding anticoagulant therapy in patients who have clinically suspected pulmonary embolism and negative results on helical CT Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003 Comparison of three clinical scoring methods in patients with pulmonary thromboembolism Source: Annual Congress 2006 - Pulmonary embolism Year: 2006 Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism Source: Eur Respir J 2013; 41: 588-592 Year: 2013 Comparison of three clinical prediction rules among patients with suspected pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 685s Year: 2004 Diagnosis and management of acute pulmonary embolism Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 263-271 Year: 2015